UFA-Preserved2: Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Obesity and HFpEF
Study Details
Study Description
Brief Summary
This study is designed to evaluate the effects of a diet rich in unsaturated fatty acids (UFA)-also known as 'healthy fats'-in patients with obesity and heart failure with preserved ejection fraction (HFpEF) on dietary consumption of UFA as well as fatty acids plasma levels.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study will evaluate participant's food consumption during 2 different 12-week periods. During one of the 12-week periods, participants will receive specific counseling and instructions on how to increase the consumption of food rich in healthy fats; during the other 12-week period they will receive general dietary recommendations following the Dietary Guidelines for Americans. There will be a 6-week break (washout) between the 12-week periods for a total of study period of 30 weeks. During each 12-week periods, the study will measure the effects of these dietary recommendations on dietary consumption and the fatty acids in their blood (primary endpoints).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: UFA dietary recommendations Dietary intervention aimed at increasing UFA consumption. |
Behavioral: UFA dietary recommendations
The face-to-face intervention will be performed by a research nutritionist that reviews the dietary recall and provides a list of commonly available foods rich in unsaturated fatty acids (UFA) (monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA)), together with individual instructions on how to integrate the recommended foods in the daily dietary pattern based on the dietary recall, and also to emphasize that the recommended food should be consumed as listed, and not as part of processed food (i.e., guacamole for avocado, hazelnut chocolate for nuts, pesto for olive oil, fish sticks for fatty fish). Extra-virgin olive oil or canola oil or nuts will be considered first choice for daily consumption of UFA-rich food, but a list of daily food substitutes will be also provided .
|
No Intervention: Standard dietary recommendations Standard of care dietary recommendations as currently performed in the clinic (2015-2020 United States Department of Agriculture (USDA) Dietary Guidelines for Americans) |
Outcome Measures
Primary Outcome Measures
- Change in 24-hour dietary recall [At baseline, at 12 weeks, at 18 weeks, and at 30 weeks]
Measured with validated 24-hour dietary recall (non-self administered)
- Change in dietary compliance (biomarkers) [At baseline, at 12 weeks, at 18 weeks, and at 30 weeks]
Measured by changes in biomarkers of unsaturated fatty acid consumption
Eligibility Criteria
Criteria
Major Inclusion Criteria:
- Body Mass Index (BMI) ≥30 kg/m2 (obesity) or total body fat percentage >25% in men and
35% in women
-
A confirmed clinical diagnosis of stable HF (New York Heart Association (NYHA) class II-III) on maximally tolerated heart failure (HF) optimal medical regimen (without major changes in the prior month)
-
Left Ventricular Ejection Fraction (LVEF)>50% documented in the prior 12 months
Major Exclusion Criteria:
-
Concomitant conditions or treatment which would affect completion or interpretation of the study (i.e.,physical inability to walk or run on treadmill);
-
Significant ischemic heart disease, angina, uncontrolled arterial hypertension, atrial fibrillation, moderate to severe valvular disease, chronic pulmonary disease, anemia (Hemoglobin<10 g/dL)
-
Electrocardiography (ECG) changes (ischemia or arrhythmias) that limit maximum exertion during cardiopulmonary exercise test
-
Comorbidity limiting survival
-
Stage IV-V kidney disease (estimated Glomerular Filtration Rate<30)
-
Fluid overload
-
Pregnancy
-
Current use of unsaturated fatty acids (UFA) supplement (i.e., omega-3).
-
Inability to give informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Virginia Commonwealth University | Richmond | Virginia | United States | 23298 |
Sponsors and Collaborators
- Virginia Commonwealth University
- American Heart Association
Investigators
- Principal Investigator: Salvatore Carbone, PhD, Virginia Commonwealth University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HM20016253